BioSpace News Archive

Press Releases

Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid

December 10, 2025
·
4 min read
Press Releases

Tessera Therapeutics Announces Chief Financial Officer (CFO) Transition and Appointment of Kathy Bergsteinsson as CFO

December 10, 2025
·
3 min read
Press Releases

LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices

December 10, 2025
·
5 min read
Press Releases

23andMe Research Institute Appoints John McLeod General Counsel and Chief Risk Officer

December 10, 2025
·
2 min read
Press Releases

Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer

December 10, 2025
·
8 min read
Press Releases

Aprea Therapeutics Announces $3.1 Million Private Placement Priced At-The-Market Under Nasdaq Rules

December 10, 2025
·
5 min read
Press Releases

Novo Nordisk has completed its acquisition of Akero Therapeutics

December 10, 2025
·
2 min read
Press Releases

CREATE Medicines Doses First Patient in Frontline HCC Trial Evaluating MT-303, an In Vivo CAR Therapy, in Combination with Standard-of-Care Immunotherapy

December 10, 2025
·
5 min read
Press Releases

Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen

December 10, 2025
·
5 min read
Press Releases

Vincere Cancer Center Begins Recruitment for Clinical Studies of Pioneering Breast Cancer Screen for Women at High Risk

December 10, 2025
·
4 min read